Jim Tananbaum - Profile and Investment Details

Investor Profile

Jim Tananbaum is a Venture Capital, Incubator, Accelerator, Founder, Private Equity Firm, Angel/Individual, CEO, Investment Partner, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Element Biosciences, Peloton Therapeutics, Genomics, Keros Therapeutics, LifeMine Therapeutics, Tarsa Therapeutics, Alumis, Juvenescence, Aimmune Therapeutics, Prospect Venture Partners, GelTex (acquired Genzyme $1.6 B), WaveTec Vision, HealthVerity, Tesseract Health, . Over time, Jim Tananbaum has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jim Tananbaum is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Data Science, Wellness, Enterprise Software, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Biotechnology, Consumer Health, Medical Devices, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Productivity Software, Precision Medicine, Consumer Software, Gene Therapy, Personalized Medicine, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Pharmaceuticals, Spatial Biology, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jim Tananbaum, as their portfolio suggests a familiarity and interest in this area.

Understanding Jim Tananbaum’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.